Evidence map›Paper›PMID 36555105›Full record

ArticleInternational journal of molecular sciences2022

Sterol O-Acyltransferase Inhibition Ameliorates High-Fat Diet-Induced Renal Fibrosis and Tertiary Lymphoid Tissue Maturation after Ischemic Reperfusion Injury.

Yuki Ariyasu, Yuki Sato, Yosuke Isobe, Keisuke Taniguchi, Motoko Yanagita, Makoto Arita

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yuki AriyasuRIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Japan.
Yuki SatoDepartment of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
Yosuke IsobeRIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Japan.
Keisuke TaniguchiDepartment of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
Motoko YanagitaDepartment of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.ORCID 0000-0002-0339-9008
Makoto AritaRIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Japan.ORCID 0000-0001-9902-0463
Kyoto University · JPKeio University · JP

Funding

Japan Science and Technology Agency JPMJER2101Japan Society for the Promotion of Science 15H05897, 15H05898, 18H04673, 20H00495RIKEN Glyco-Lipidologue InitiativeRIKEN Junior Research Associate Program
6 · The paper itself

Abstract

Metabolic syndrome is associated with the development of chronic kidney disease (CKD). We previously demonstrated that aged kidneys are prone to developing tertiary lymphoid tissues (TLTs) and sustain inflammation after injury, leading to CKD progression; however, the relationship between renal TLT and metabolic syndrome is unknown. In this study, we demonstrated that a high-fat diet (HFD) promoted renal TLT formation and inflammation via sterol O-acyltransferase (SOAT) 1-dependent mechanism. Mice fed a HFD prior to ischemic reperfusion injury (IRI) exhibited pronounced renal TLT formation and sustained inflammation compared to the controls. Untargeted lipidomics revealed the increased levels of cholesteryl esters (CEs) in aged kidneys with TLT formation after IRI, and, consistently, the

Indexed as

Metabolic DiseasesMetabolic SyndromeRenal Insufficiency, ChronicReperfusion InjuryAnimalsDiet, High-FatFibrosisInflammationKidneyLymphoid TissueMiceMice, Inbred C57BLSterol O-AcyltransferaseSterol O-Acyltransferasecholesteryl esterchronic kidney diseasehigh-fat dietlipidomicsmetabolic syndromesterol O-acyltransferasetertiary lymphoid tissue

Identifiers

PMID36555105
PMCPMC9779122
OpenAlexW4311718193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.